ABCAM PLC/ADR (OTCMKTS:ABCZY) Upgraded at Zacks Investment Research

Share on StockTwits

ABCAM PLC/ADR (OTCMKTS:ABCZY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Monday, Zacks.com reports.

According to Zacks, “Abcam PLC distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam PLC is headquartered in Cambridge, the United Kingdom. “

Separately, ValuEngine upgraded ABCAM PLC/ADR from a “hold” rating to a “buy” rating in a report on Wednesday, October 2nd.

OTCMKTS:ABCZY traded down $0.60 during midday trading on Monday, hitting $13.80. 1,330 shares of the company traded hands, compared to its average volume of 1,340. The firm’s fifty day moving average is $14.45 and its 200-day moving average is $16.39. ABCAM PLC/ADR has a 12-month low of $12.52 and a 12-month high of $19.25.

About ABCAM PLC/ADR

Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies; ELISA, matched antibody pairs and multiplex immunoassays; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex miRNA assays.

Recommended Story: Consumer behavior in bull markets

Get a free copy of the Zacks research report on ABCAM PLC/ADR (ABCZY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for ABCAM PLC/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ABCAM PLC/ADR and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Narwhal Capital Management Has $2.62 Million Holdings in Maxim Integrated Products Inc.
Narwhal Capital Management Has $2.62 Million Holdings in Maxim Integrated Products Inc.
Target Co.  Shares Acquired by Narwhal Capital Management
Target Co. Shares Acquired by Narwhal Capital Management
Narwhal Capital Management Increases Position in BlackRock, Inc.
Narwhal Capital Management Increases Position in BlackRock, Inc.
Citigroup Inc  Shares Sold by Narwhal Capital Management
Citigroup Inc Shares Sold by Narwhal Capital Management
MITSUBISHI CHEM/ADR  Cut to “Sell” at ValuEngine
MITSUBISHI CHEM/ADR Cut to “Sell” at ValuEngine
YRC Worldwide  Raised to Hold at Zacks Investment Research
YRC Worldwide Raised to Hold at Zacks Investment Research


© 2006-2019 Ticker Report